NCDRC orders JnJ to pay Rs 35 lakh compensation for faulty hip replacement device Yakshi Chugh3 Oct 2024 6:07 PM ISTIn a significant ruling, the National Consumer Disputes Redressal Commission (NCDRC) has ordered Johnson & Johnson Limited to compensate a...
Apex Consumer Court slaps Rs 35 lakh compensation on Johnson & Johnson for faulty hip replacement device Ruchika Sharma1 Oct 2024 12:35 PM ISTNew Delhi: In a significant ruling, the National Consumer Disputes Redressal Commission (NCDRC) has ordered Johnson & Johnson Limited to...
Darzalex-based quadruplet regimen receives positive CHMP opinion for transplant-eligible patients with newly diagnosed multiple myeloma Ruchika Sharma22 Sept 2024 12:30 PM ISTBeerse: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the Committee for Medicinal Products for Human Use...
JnJ gets USFDA nod for Rybrevant plus standard of care chemotherapy for lung cancer treatment Ruchika Sharma21 Sept 2024 4:00 PM ISTRaritan: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved RYBREVANT (amivantamab-vmjw) in...
JnJ seeks approval of nipocalimab to treat generalized myasthenia gravis Ruchika Sharma2 Sept 2024 4:29 PM ISTSpring House: Johnson & Johnson has announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug...
European Commission approves Janssen-Cilag Balversa for adult patients with metastatic urothelial carcinoma Ruchika Sharma25 Aug 2024 10:00 AM ISTBelgium: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the European Commission (EC) has approved...
JnJ chemotherapy free lung cancer treatment Rybrevant plus Lazcluze gets USFDA okay Ruchika Sharma21 Aug 2024 12:30 PM ISTNew Jersey: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved RYBREVANT (amivantamab-vmjw) plus...
Johnson & Johnson to acquire V-Wave Ruchika Sharma21 Aug 2024 10:00 AM ISTNew Brunswick: Johnson & Johnson has announced that it has entered into a definitive agreement to acquire V-Wave Ltd., a privately-held...
EMA Committee recommends Rybrevant in combo with chemotherapy for adult patients with lung cancer after failure of prior therapy Ruchika Sharma4 Aug 2024 11:00 AM ISTBeerse: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the Committee for Medicinal Products for Human Use...
JnJ gets USFDA nod for Darzalex Faspro-based quadruplet regimen for newly diagnosed multiple myeloma who are transplant-eligible Ruchika Sharma2 Aug 2024 11:30 AM ISTHorsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved DARZALEX FASPRO (daratumumab and...
Johnson & Johnson beat estimates for Q2 profit, revenue Ruchika Sharma18 July 2024 4:53 PM ISTLondon:Johnson & Johnson exceeded expectations in its second-quarter profit and revenue announced on Wednesday, propelled by robust sales of its...
JnJ strengthens atopic dermatitis pipeline with acquisition of Yellow Jersey Therapeutics Ruchika Sharma14 July 2024 12:30 PM ISTNew Brunswick: Johnson & Johnson has announced that it has successfully completed the acquisition of Yellow Jersey, a demerged...
